Date Published:
2015 Feb

Publication Type:
Journal Article

Authors:

A.D. Thames
S.A. Castellon
E.J. Singer
R. Nagarajan
M.K. Sarma
J. Smith
N.S. Thaler
J.Hien Truong
D. Schonfeld
A. Thomas
C.H. Hinkin

Secondary:
Neurol Neuroimmunol Neuroinflamm

Volume:
2

Pagination:
e59

Issue:
1

PMID:
25610883

URL:
https://pubmed.ncbi.nlm.nih.gov/25610883

DOI:
10.1212/NXI.0000000000000059

Keywords:
Internal

Abstract:
<p><strong>OBJECTIVE: </strong>This study examined neurologic abnormalities (as measured by proton magnetic resonance spectroscopy imaging and diffusion tensor imaging), neurocognitive performance, and fatigue among a sample of adults with hepatitis C virus (HCV). We hypothesized that HCV+ individuals would demonstrate structural brain abnormalities and neurocognitive compromise consistent with frontostriatal dysfunction as well as increased fatigue compared to controls.<strong>METHOD: </strong>Participants were 76 individuals diagnosed with HCV and 20 controls who underwent a comprehensive neurocognitive evaluation and clinical assessments. A subset of the HCV+ participants (n = 29) and all controls underwent MRI.<strong>RESULTS: </strong>Individuals diagnosed with chronic HCV infection demonstrated greater fractional anisotropy in the striatum as well as greater mean diffusivity in the fronto-occiptal fasciculus and external capsule compared to HCV- controls. HCV+ participants also demonstrated lower levels of N-acetylaspartate in bilateral parietal white matter and elevations in myo-inosital (mI) in bilateral frontal white matter compared to HCV- controls (all p values < 0.05). HCV+ participants also demonstrated significantly poorer neuropsychological performance, particularly in processing speed and verbal fluency. HCV+ patients reported higher levels of fatigue than controls, and fatigue was significantly correlated with diffusivity in the superior fronto-occipital fasciculus, elevations in mI in frontal white matter, and overall cognitive performance.<strong>CONCLUSIONS: </strong>Our results suggest that HCV-associated neurologic complications disrupt frontostriatal structures, which may result in increased fatigue and poorer cognitive performance, particularly in those cognitive domains regulated by frontostriatal regions.</p>